ARTICLE | Distillery Therapeutics
Cancer
October 17, 2017 4:50 PM UTC
In vitro, cell culture and mouse studies suggest inhibiting SHMT2 could help treat colorectal cancer and B cell malignancies. Optimization and testing in vitro of a previously identified pyrazolopyran...
BCIQ Company Profiles
BCIQ Target Profiles